NCT03968939View on ClinicalTrials.gov

Total Joint Arthroplasty and Sleep

PHASE4CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

March 1, 2022

Study Completion Date

May 22, 2022

Conditions
Primary Total Hip ArthroplastyPrimary Total Knee Arthroplasty
Interventions
DRUG

Diphenhydramine (Benadryl)

Oral Diphenhydramine (Benadryl), 25 mg

DIETARY_SUPPLEMENT

Melatonin

Oral Melatonin, 3 mg

BEHAVIORAL

Sleep Hygiene Education

"Brochure containing information about getting a good night's sleep."

Trial Locations (1)

65212

Vicki L Jones, Columbia

All Listed Sponsors
lead

James A. Keeney

OTHER

NCT03968939 - Total Joint Arthroplasty and Sleep | Biotech Hunter | Biotech Hunter